Linc-ing the Noncoding Genome to Heart Function: Beating Hypertrophy

Trends in Molecular Medicine

Volumn 23, Issue 7, 2017, Pages 577-579

  Chatterjee, Shambhabi ^a   Bär, Christian ^a   Thum, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

cardiac hypertrophy; cardiovascular disease; diagnostics; long noncoding RNA; ncRNA biomarker; therapeutics

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA;

AUTOPHAGY; CARDIAC MUSCLE CELL; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; GENE EXPRESSION; GENE INTERACTION; GENOME; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; POLYADENYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; CARDIOMEGALY; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM; PATHOLOGY;

ANIMALS; CARDIOMEGALY; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; RNA, LONG NONCODING;

EID: 85019979362     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2017.05.007     Document Type: Short Survey

References (10)

1. Shimizu, I., Minamino, T., Physiological and pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 97 (2016), 245–262.
2. Bär, C., et al. Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy. Circulation 134 (2016), 1484–1499.
3. Beermann, J., et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol. Rev. 96 (2016), 1297–1325.
4. Xue, Z., et al. A G-rich motif in the lncRNA Braveheart interacts with a zinc-finger transcription factor to specify the cardiovascular lineage. Mol. Cell 64 (2016), 37–50.
5. Wang, K., et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ. Res. 114 (2014), 1377–1388.
6. Han, P., et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature 514 (2014), 102–106.
7. Viereck, J., et al. Long noncoding RNA Chast promotes cardiac remodeling. Sci. Transl. Med., 8, 2016, 326ra22.
8. Wang, Z., et al. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat. Med. 22 (2016), 1131–1139.
9. Ling, H., et al. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 12 (2013), 847–865.
10. Viereck, J., Thum, T., Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ. Res. 120 (2017), 381–399.